Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
Lucy Platt, Silvia Minozzi, Jennifer Reed, Peter Vickerman, Holly Hagan, Clare French, Ashly Jordan, Louisa Degenhardt, Vivian Hope, Sharon Hutchinson, Lisa Maher, Norah Palmateer, Avril Taylor, Julie Bruneau, Matthew Hickman
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | WILEY | Published : 2017
Awarded by NIHR's Public Health Research Programme
Awarded by NIHR Health Protection Research Unit in Evaluation of Interventions at University of Bristol
Awarded by European Commission Drug Prevention and Information Programme (DIPP)
Awarded by NIH-NIDA
National Institute of Health Research (NIHR), UK.The project was funded by the NIHR's Public Health Research Programme (grant number: 12/3070/13). Clare French was funded by the NIHR Health Protection Research Unit in Evaluation of Interventions at University of Bristol (grant number: HPRU-2012-10026). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.European Commission Drug Prevention and Information Programme (DIPP) Grant "Treatment as Prevention in Europe: Model Projections of Impact And Strengthening Evidence Base On Intervention Coverage and Effect and HCV Morbidity". [JUST/2013/DPIP/AG/4812], Other.National Institutes of Health/National Institute on Drug Abuse (NIDA), USA.Holly Hagan, Ashly Jordan and Jennifer Reed are supported by NIH-NIDA grant [1 R01 DA034637]Lisa Maher is supported by an Australian National Health and Medical Research Council Senior Research Fellowship, Australia.